0001415889-23-014792.txt : 20231103 0001415889-23-014792.hdr.sgml : 20231103 20231103213906 ACCESSION NUMBER: 0001415889-23-014792 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231101 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Myles David C. CENTRAL INDEX KEY: 0001831216 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39712 FILM NUMBER: 231377903 MAIL ADDRESS: STREET 1: C/O OLEMA PHARMACEUTICALS, INC. STREET 2: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001750284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300409740 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 651-3316 MAIL ADDRESS: STREET 1: 780 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 4 1 form4-11042023_011159.xml X0508 4 2023-11-01 0001750284 Olema Pharmaceuticals, Inc. OLMA 0001831216 Myles David C. C/O OLEMA PHARMACEUTICALS, INC. 780 BRANNAN ST SAN FRANCISCO CA 94103 false true false false CH. DISCOV. & NON-CLIN DEV OFF 1 Common Stock 2023-11-01 4 S 0 6668 15.02 D 565343 D Common Stock 2023-11-02 4 S 0 3332 15.36 D 562011 D Common Stock 2023-11-03 4 S 0 541 17.51 D 561470 D Common Stock 12831 I See Footnote Common Stock 154846 I See Footnote The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person dated June 20, 2023. The weighted average sale price for the transaction reported was $15.02, and the range of prices were between $15.00 and $15.09. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $15.36, and the range of prices were between $15.01 and $15.74. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $17.51, and the range of prices were between $17.50 and $17.53. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The shares are held by The Myles Family Revocable Inter Vivos Trust, of which the Reporting Person is trustee. The shares are held by Myles Properties Inc., of which the Reporting Person is President. /s/ Shane Kovacs, Attorney-in-Fact 2023-11-03